Consolidated Statements of Cash Flows - USD ($)		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss		$ (6,074,952)	$ (6,327,658)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities
Impairment charge		3,599,322
Stock-based compensation		242,679	572,177
Depreciation and amortization	[1]	1,389,145	1,042,829
Deferred income tax benefit			1,425,414
Recovery on contingent earnout			(200,000)
Bad debt expense		140,044
(Increase)/decrease in operating assets
Accounts receivable		1,357,765	1,519,683
Contract assets		18,671	844,846
Inventories		585,874	152,160
Tax receivable		(715,599)
Other current assets		24,162
Other assets			125,056
Increase/(decrease) in operating liabilities
Accounts payable		282,539	(177,801)
Accrued expenses		(493,819)	315,195
Contract liabilities		(1,488,579)	1,278,813
Total adjustments		4,942,204	6,898,372
Net cash (used in) provided by operating activities		(1,132,748)	570,714
Cash flows from investing activities:
Capital expenditures		(1,577,175)	(2,688,231)
Net cash used in investing activities		(1,577,175)	(2,688,231)
Cash flows from financing activities
Proceeds from Payroll Protection Plan Loan		2,415,970
Payments of long-term debt		(670,965)	(657,591)
Net cash provided by (used) in financing activities		1,745,005	(657,591)
Net decrease in cash and cash equivalents		(964,918)	(2,775,108)
Cash and cash equivalents at beginning of period		8,664,253	11,439,361
Cash and cash equivalents at end of period		7,699,335	8,664,253
Supplemental disclosure of cash flow information:
Income taxes paid		3,040	2,800
Interest paid		445,109	365,254
Supplemental disclosure of non-cash investing and financing activities:
Capitalization of right to use Asset			$ 84,354

[1] Includes amortization expense of $124,550 and $120,488 for the year ending December 31, 2020 and the year ended December 31, 2019, respectively. Such amortization expense relates to other capitalized and intangibles assets.